np event 2254995 0E193A 1
May 9, 2026
- May 9, 2027
Des experts internationaux évaluent de nouvelles données sur l’inhibition de l’aldostérone synthase dans la prise en charge de l’hypertension difficile à contrôler, à l’intention des professionnels de santé de premier recours
0.75

Claim your CME or CE credits

Already have an Account? Log In
Don’t have an account? Register Today

 Claim your Certificate

Related Courses

np microphone 888718 0E193A 1
Pulmonology
Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease...
np document 888746 0E193A 5
Neurology
Clinical Update on the Evolving Role of B-Cell Targeting Therapies to Improve Outcomes in ...
np document 888746 0E193A 5
Neurology
Beyond Symptom Control: Targeting BAFF/APRIL Pathways in Generalized Myasthenia Gravis